111 related articles for article (PubMed ID: 9177919)
21. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
[TBL] [Abstract][Full Text] [Related]
22. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis.
Ishiguro N; Ito T; Ito H; Iwata H; Jugessur H; Ionescu M; Poole AR
Arthritis Rheum; 1999 Jan; 42(1):129-36. PubMed ID: 9920023
[TBL] [Abstract][Full Text] [Related]
23. Levels of rheumatoid factor isotypes, metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in synovial fluid from various arthritides.
Kageyama Y; Miyamoto S; Ozeki T; Hiyohsi M; Suzuki M; Nagano A
Clin Rheumatol; 2000; 19(1):14-20. PubMed ID: 10752493
[TBL] [Abstract][Full Text] [Related]
24. Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagenase) and 3 (stromelysin) and tissue inhibitor metalloproteinase 1 by human rheumatoid synovial fibroblasts.
Hiraoka K; Sasaguri Y; Komiya S; Zenmyo M; Inoue A; Morimatsu M
Exp Mol Pathol; 1993 Dec; 59(3):169-76. PubMed ID: 8137899
[TBL] [Abstract][Full Text] [Related]
25. Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay.
Beekman B; van El B; Drijfhout JW; Ronday HK; TeKoppele JM
FEBS Lett; 1997 Dec; 418(3):305-9. PubMed ID: 9428733
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis.
Coughlan AR; Robertson DH; Bennett D; May C; Beynon RJ; Carter SD
Vet Rec; 1998 Aug; 143(8):219-23. PubMed ID: 9770764
[TBL] [Abstract][Full Text] [Related]
27. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection.
Makowski GS; Ramsby ML
Clin Chim Acta; 2003 Mar; 329(1-2):77-81. PubMed ID: 12589968
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
29. Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).
Nagase H; Suzuki K; Cawston TE; Brew K
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):163-7. PubMed ID: 9224642
[TBL] [Abstract][Full Text] [Related]
30. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
31. Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis.
Momohara S; Kashiwazaki S; Inoue K; Saito S; Nakagawa T
Clin Rheumatol; 1997 Mar; 16(2):133-40. PubMed ID: 9093794
[TBL] [Abstract][Full Text] [Related]
32. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines.
Unemori EN; Hibbs MS; Amento EP
J Clin Invest; 1991 Nov; 88(5):1656-62. PubMed ID: 1658048
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid.
Osthues A; Knäuper V; Oberhoff R; Reinke H; Tschesche H
FEBS Lett; 1992 Jan; 296(1):16-20. PubMed ID: 1730286
[TBL] [Abstract][Full Text] [Related]
34. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous production of collagenase, matrix metalloproteinase 3 (stromelysin) and tissue inhibitor of metalloproteinases by rheumatoid synovial lining cells.
Okada Y; Takeuchi N; Gonoji Y; Nakanishi I; Nagase H; Hayakawa T
Matrix Suppl; 1992; 1():398-9. PubMed ID: 1480071
[No Abstract] [Full Text] [Related]
36. The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient.
Kolb C; Mauch S; Peter HH; Krawinkel U; Sedlacek R
Immunol Lett; 1997 Jun; 57(1-3):83-8. PubMed ID: 9232430
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
Samples JR; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3386-95. PubMed ID: 8225873
[TBL] [Abstract][Full Text] [Related]
38. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis.
Lohmander LS; Hoerrner LA; Lark MW
Arthritis Rheum; 1993 Feb; 36(2):181-9. PubMed ID: 8431206
[TBL] [Abstract][Full Text] [Related]
39. The levels of collagenase, tissue inhibitor of metalloproteinases-1 (TIMP-1), collagenase approximately TIMP-1 complexes and glycosaminoglycan (GAG) in sequential samples of synovial fluid aspirated from patients with osteoarthritis.
Cawston TE; Curry V; Ramsey S; Clark IM; Kyle VA; Adebajo A; Silverman B; Daymond T; Hazleman BL
Clin Exp Rheumatol; 1995; 13(4):431-7. PubMed ID: 7586773
[TBL] [Abstract][Full Text] [Related]
40. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
